The horrors of shared docs

Long long ago, colleagues would suggest changes to documents sequentially. They would make comments and add revisions to a file on their own computer, and then send it on to the next person. It was inefficient and opaque. The era of the shared doc has made this process much more user-friendly and transparent. But like…

Read More

This is Europe’s ‘global euro’ moment

Stay informed with free updates Simply sign up to the Currencies myFT Digest — delivered directly to your inbox. The writer is president of the European Central Bank We are witnessing a profound shift in the global order: open markets and multilateral rules are fracturing, and even the dominant role of the US dollar, the…

Read More

The luxury industry is poised for a deal wave

A shopping spree looks set to begin in the world of luxury. Prada, one big-name Italian brand, is said to be in talks to buy another, Versace. On March 13th Donatella Versace stepped down as chief designer of the firm founded by her brother. Giorgio Armani, the 90-year-old founder of his eponymous label, has said…

Read More

Return of the American assassin

Unlock the White House Watch newsletter for free Your guide to what Trump’s second term means for Washington, business and the world People are not always what they seem. Vance Luther Boelter is a Christian preacher with a residential security company. Last weekend he is suspected of killing the former Speaker of the Minnesota legislature…

Read More

New perks, $795 annual fee

The Chase Sapphire Lounge at LaGuardia Airport, accessible only to Sapphire Reserve customers. Benji Stawski / CNBC JPMorgan Chase is betting that a long list of new perks will keep affluent Americans hooked on its Sapphire Reserve card, despite a hefty bump in its annual fee. The bank on Tuesday unveiled an update to its…

Read More

Pfizer, AstraZeneca, Merck bet on chemo replacement

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its…

Read More